HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
HCW Biologics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.23−0.01 (-0.81%)
Close on Oct 19, 2026
- Market cap
- $1.63M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$54.23KFY2025, -57.9% a year since FY2020